| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
61,398,000 |
| Market
Cap: |
313.74(M) |
| Last
Volume: |
763,512 |
Avg
Vol: |
703,614 |
| 52
Week Range: |
$3.38 - $6.66 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
| |
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 803 |
| Guru Rank Value : 1 |
| Guru Occurances : 1 |
|
|
|
|
|
| |
|
Company Profile Vanda Pharmaceuticals is a biopharmaceutical company. Co.'s commercial portfolio is comprised of two products, HETLIOZ® for the treatment of Non-24 Sleep-Wake Disorder (Non-24) and nighttime sleep disturbances in Smith-Magenis Syndrome and Fanapt® for the treatment of schizophrenia. In addition, Co. has a number of drugs in development, including: Tradipitant (VLY-686), a small molecule neurokinin-1 receptor antagonist, for the treatment of gastroparesis, motion sickness, atopic dermatitis, and COVID-19 pneumonia; and VTR-297, a small molecule histone deacetylase inhibitor for the treatment of hematologic malignancies and with potential use as a treatment for several oncology indications.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
121,098 |
121,098 |
148,134 |
381,657 |
| Total Sell Value |
$513,345 |
$513,345 |
$684,141 |
$2,671,384 |
| Total People Sold |
5 |
5 |
6 |
7 |
| Total Sell Transactions |
10 |
10 |
14 |
32 |
| End Date |
2024-03-03 |
2023-12-01 |
2023-06-02 |
2022-06-02 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Leschly Jan |
10% Owner |
– – • |
2006-11-17 |
4 |
S |
$14.25 |
$3,847,500 |
I/I |
(270,000) |
313,705 |
|
- |
|
| Karabelas Argeris N |
Chairman of the Board |
• • – |
2006-11-17 |
4 |
S |
$14.25 |
$3,847,500 |
I/I |
(270,000) |
313,705 |
|
- |
|
| Edb Investments Pte Ltd. |
10% Owner |
– – • |
2006-11-17 |
4 |
S |
$14.30 |
$715,100 |
I/I |
(50,000) |
2,496,957 |
|
- |
|
| Rho Management Trust I |
10% Owner |
– – • |
2006-11-15 |
4 |
S |
$14.96 |
$8,090,236 |
I/I |
(540,000) |
1,862,692 |
|
- |
|
| Edb Investments Pte Ltd. |
10% Owner |
– – • |
2006-11-15 |
4 |
S |
$15.13 |
$389,051 |
I/I |
(25,711) |
2,546,957 |
|
- |
|
| Clark William D |
Sr VP, Chief Business Officer |
• – – |
2006-11-08 |
4 |
S |
$11.55 |
$72,792 |
D/D |
(6,300) |
0 |
|
- |
|
| Clark William D |
Sr VP, Chief Business Officer |
• – – |
2006-11-08 |
4 |
S |
$11.00 |
$136,967 |
D/D |
(12,300) |
6,300 |
|
- |
|
| Clark William D |
Sr VP, Chief Business Officer |
• – – |
2006-11-08 |
4 |
OE |
$0.33 |
$6,138 |
D/D |
18,600 |
18,600 |
|
- |
|
| Polymeropoulos Mihael Hristos |
Chief Executive Officer |
• • – |
2006-11-07 |
4 |
S |
$11.70 |
$13,213 |
D/D |
(1,127) |
0 |
|
- |
|
| Polymeropoulos Mihael Hristos |
Chief Executive Officer |
• • – |
2006-11-07 |
4 |
OE |
$0.33 |
$372 |
D/D |
1,127 |
1,127 |
|
- |
|
| Clark William D |
Sr VP, Chief Business Officer |
• – – |
2006-11-07 |
4 |
S |
$11.50 |
$4,622 |
D/D |
(400) |
0 |
|
- |
|
| Clark William D |
Sr VP, Chief Business Officer |
• – – |
2006-11-07 |
4 |
OE |
$0.33 |
$132 |
D/D |
400 |
400 |
|
- |
|
| Rho Management Trust I |
10% Owner |
– – • |
2006-11-06 |
4 |
S |
$11.79 |
$158,823 |
I/I |
(13,474) |
2,402,692 |
|
- |
|
| Rho Management Trust I |
10% Owner |
– – • |
2006-11-06 |
4 |
A |
$0.00 |
$0 |
I/I |
13,474 |
2,416,166 |
|
- |
|
| Polymeropoulos Mihael Hristos |
Chief Executive Officer |
• • – |
2006-11-06 |
4 |
S |
$11.70 |
$191,213 |
D/D |
(16,200) |
0 |
|
- |
|
| Polymeropoulos Mihael Hristos |
Chief Executive Officer |
• • – |
2006-11-06 |
4 |
OE |
$0.33 |
$5,346 |
D/D |
16,200 |
16,200 |
|
- |
|
| Hirsch Russell C |
10% Owner |
– – • |
2006-11-03 |
4 |
D |
$0.00 |
$0 |
I/I |
(921,149) |
22,223 |
|
- |
|
| Tananbaum James B |
Director |
– • – |
2006-11-03 |
4 |
A |
$0.00 |
$0 |
D/D |
2,303 |
2,303 |
|
- |
|
| Tananbaum James B |
Director |
– • – |
2006-11-03 |
4 |
D |
$0.00 |
$0 |
I/I |
(921,149) |
22,223 |
|
- |
|
| Vitullo Nicole |
10% Owner |
– – • |
2006-11-03 |
4 |
A |
$0.00 |
$0 |
I/I |
10,675 |
10,675 |
|
- |
|
| Vitullo Nicole |
10% Owner |
– – • |
2006-11-03 |
4 |
D |
$0.00 |
$0 |
I/I |
(634,000) |
2,535,626 |
|
- |
|
| More Robert J |
10% Owner |
– – • |
2006-11-03 |
4 |
A |
$0.00 |
$0 |
I/I |
10,675 |
10,675 |
|
- |
|
| More Robert J |
10% Owner |
– – • |
2006-11-03 |
4 |
D |
$0.00 |
$0 |
I/I |
(634,000) |
2,535,626 |
|
- |
|
| Schoemaker Kathleen K |
10% Owner |
– – • |
2006-11-03 |
4 |
A |
$0.00 |
$0 |
I/I |
10,675 |
10,675 |
|
- |
|
| Schoemaker Kathleen K |
10% Owner |
– – • |
2006-11-03 |
4 |
D |
$0.00 |
$0 |
I/I |
(634,000) |
2,535,626 |
|
- |
|
554 Records found
|
|
Page 21 of 23 |
|
|
0.10 (2%) 
